Status:
COMPLETED
Clinical Evaluation of Morcher Artificial Iris Diaphragms
Lead Sponsor:
University of California, Los Angeles
Conditions:
Aniridia
Iris; Deformity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the safety and efficacy of Morcher iris diaphragms in the treatment of congenital and acquired aniridia. Morcher iris diaphragms are intraocular devices that ...
Detailed Description
Aniridia is a condition in which the iris, the colored portion of the eye, is either partially or completely absent. The iris is responsible for regulating the amount of light entering the eye by adju...
Eligibility Criteria
Inclusion
- Patient must be 18 years old and have partial or complete aniridia.
- Be willing and able to comply with all follow-up requirements.
- Must have increased light and/or glare sensitivity or complete aniridia.
- Patients may be phakic, aphakic, or pseudophakic.
- Phakic patients will require simultaneous cataract surgery.
- Aphakic patients will require secondary intraocular lens implantation.
Exclusion
- The presence of any ocular condition that may cause complications from the surgical procedure
- Active ocular infection or inflammation
- Patients with allergies to operative and/or postoperative medications
- Pregnant or lactating women
- Persons who, in the determination of the investigator, are not competent to understand the procedure or the actions asked of them as research subjects
Key Trial Info
Start Date :
April 9 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2021
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00812708
Start Date
April 9 2003
End Date
December 7 2021
Last Update
December 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stein Eye Institute, UCLA
Los Angeles, California, United States, 90095-7000